Stewart-Treves Syndrome: Essential Guide For Patients

Stewart–Treves syndrome is a cutaneous lymphangiosarcoma that develops in lymphoedema following mastectomy with axillary node clearance or axillary radiation.

Introduction

Stewart–Treves syndrome represents a rare and highly aggressive malignancy characterized by the development of cutaneous lymphangiosarcoma in areas of chronic, persistent lymphedema. First documented in 1948 by Drs. Fred W. Stewart and Norman Treves, it was initially observed in patients who had undergone radical mastectomy for breast cancer, leading to severe post-surgical lymphedema in the upper limb. The syndrome is named after these pathologists who reported a series of six cases, highlighting the association between long-standing lymphatic obstruction and the emergence of angiosarcoma.

Although classically linked to post-mastectomy lymphedema, the term has broadened to encompass lymphangiosarcomas arising in any context of primary congenital or secondary chronic lymphedema. This includes hereditary conditions such as Milroy disease, lymphedema praecox, lymphedema tarda, Turner syndrome, and Noonan syndrome, as well as non-cancer-related causes like chronic infections, venous stasis, morbid obesity, and surgical disruptions to lymphatic flow. The condition typically manifests only after years of substantial and unremitting lymphedema, underscoring the role of prolonged lymphatic stasis in oncogenesis.

With an incidence of approximately 1 in 200 patients surviving more than five years post-mastectomy, the average latency period is about 10.5 years. Advancements in breast cancer management, including less invasive surgical techniques like sentinel lymph node biopsy and reduced reliance on radical axillary dissection or radiotherapy, have contributed to a declining incidence of chronic lymphedema and thus Stewart-Treves syndrome. Nonetheless, vigilance remains crucial in patients with persistent limb swelling.

Demographics

Stewart-Treves syndrome predominantly affects women who have undergone treatment for breast cancer, particularly those subjected to radical mastectomy with axillary lymph node dissection. Historical data indicate it occurs in 0.45% to 1% of such patients, though contemporary rates are lower due to refined surgical practices. The mean age at diagnosis is around 60-70 years, aligning with the typical age of breast cancer presentation and the decade-long latency.

While upper limb involvement post-mastectomy accounts for over 90% of cases, rare instances occur in the lower extremities, often linked to obesity-associated lymphedema or other chronic causes. A case report described a 63-year-old morbidly obese woman developing angiosarcoma in the right lower leg after longstanding edema, illustrating atypical presentations. Men are infrequently affected, usually in contexts of other malignancies or congenital lymphedema. Globally, fewer than 400 cases have been documented, emphasizing its rarity.

Causes

The precise pathophysiology of Stewart-Treves syndrome remains elusive, but chronic lymphedema is the sine qua non. Prolonged lymphatic obstruction leads to tissue hypoxia, chronic inflammation, and impaired immune surveillance, fostering a microenvironment conducive to malignant transformation of endothelial cells. Hypotheses include:

• Impaired lymphatic drainage creating an ‘immunologically privileged site’ with reduced antigen presentation, allowing neoplastic cells to evade detection.
• Establishment of collateral circulation in lymphedematous tissue promoting neoplastic change.
• Systemic carcinogenic factors or lymphatic blockage-induced malignant transformation.
• Overexpression of oncogenes like c-myc, as identified in recent molecular studies.

In obesity-associated cases, adipocyte hypertrophy induces lymphatic fibrosis, stasis, and inflammatory macrophage infiltration, which may drive lymphangiogenesis and malignancy via cytokine release. Predisposing factors encompass radical surgeries (e.g., mastectomy with axillary clearance), radiotherapy, congenital lymphatic malformations, filarial infections, and post-surgical or post-irradiation lymphedema from other cancers.

Clinical features

The hallmark is the emergence of multifocal cutaneous lesions within an area of chronic, severe lymphedema, typically the ipsilateral upper limb following mastectomy. Initial signs include persistent edema extending from the arm to the forearm, hand dorsum, and fingers, often with skin thickening and recurrent erysipelas.

Lesions commence as asymptomatic reddish-blue or purple macules, plaques, or nodules, resembling bruises (1-6 cm average size), which coalesce into larger infiltrative areas. Progression involves polypoid growth, bullae formation, satellite lesions, ulceration, necrosis, hemorrhage, and fungation. Pain is uncommon early but arises from skin distension or secondary infection. Advanced disease features rapid local spread, lymphedema exacerbation, and distant metastases.

In non-classical sites like the lower leg, presentations mirror upper limb cases but may be delayed due to less clinical scrutiny.

Complications

Beyond local tumor progression, complications include recurrent bacterial cellulitis or erysipelas due to disrupted skin barriers and lymphatic impairment, deep vein thrombosis from venous compression, chronic pain, functional limb disability, hemorrhage from ulcerated lesions, and systemic metastasis (lungs, liver, bones) leading to respiratory distress or multiorgan failure.

Morbidity is high from wound infections, sepsis, and immobility; mortality approaches 100% within 2-3 years post-diagnosis, primarily from metastases.

Diagnosis

Suspicion arises in chronic lymphedema with new multifocal purplish nodules or plaques. Confirmation requires full-thickness skin biopsy, revealing anastomosing vascular channels dissecting dermal collagen, lined by atypical, hyperchromatic, pleomorphic endothelial cells with mitoses, necrosis, and lymphovascular invasion.

Immunohistochemistry shows positivity for CD31, CD34, ERG, and D2-40, distinguishing lymphangiosarcoma from mimics. Imaging (MRI, PET-CT) assesses extent and metastases; lymphoscintigraphy confirms underlying lymphedema.

Differential diagnoses

Treatment

No standardized curative therapy exists owing to aggressiveness and multimodality resistance. Management is palliative and multidisciplinary:

• Surgery: Wide local excision or amputation (e.g., forequarter for upper limb) offers local control but high recurrence (50-70%).
• Radiotherapy: Adjuvant or palliative for unresectable disease; hypofractionated regimens control symptoms.
• Chemotherapy: Anthracyclines (doxorubicin), taxanes, paclitaxel; modest response rates (20-50%), used for metastases.
• Targeted therapies: Emerging anti-angiogenics (pazopanib, sorafenib), immunotherapy (pembrolizumab for high MSI/PD-L1); variable efficacy.
• Supportive: Compression, elevation, antibiotics for infections, pain control.

Early detection via vigilant skin surveillance in lymphedema patients improves outcomes.

Outcome

Prognosis is dismal: median survival 2.5 years, with most succumbing within 2 years to metastatic disease (lungs 50%, liver 25%). Five-year survival <10-20%; amputation may extend local control but not overall survival. Factors worsening prognosis: size >5cm, truncal involvement, metastases at diagnosis. Declining incidence with modern oncology offers hope, but mortality remains near-universal once diagnosed.

Frequently Asked Questions

What is Stewart-Treves syndrome?

A rare angiosarcoma arising in chronic lymphedema, often post-mastectomy.

Who is at risk?

Patients with long-standing lymphedema from surgery, radiation, obesity, or congenital causes.

How is it diagnosed?

Skin biopsy showing malignant vascular channels with IHC confirmation.

What is the prognosis?

Poor; median survival ~2.5 years, high metastatic rate.

Can it be prevented?

Minimize lymphedema via modern surgical techniques and vigilant monitoring.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb